 compar thrombolyt properti bolu inject continu infus chimer t-pa/u-pa plasminogen activ hamster pulmonari embol model recombin chimer plasminogen activ rt-pa-delta fe/scu-pa- amino acid tissue-typ plasminogen activ t-pa amino acid single-chain urokinase-typ plasminogen activ scu-pa thrombolyt potenc continu intraven infus anim model venou thrombosi collen circul press present studi thrombolyt potenc intraven bolu inject rt-pa-delta fe/scu-pa- recombin t-pa rt-pa recombin scu-pa rscu-pa combin intraven infus hamster pulmonari embol model dose-depend clot lysi absenc system activ fibrinolyt system fibrinogen breakdown bolu inject experi maxim rate clot lysi percent clot lysi compound rt-pa rscu-pa rt-pa-delta fe/scu-pa- rt-pa rscu-pa compar result continu infus hour rt-pa rscu-pa percent lysi mg/kg compound rt-pa rscu-pa rt-pa-delta fe/scu-pa- rt-pa rscu-pa potent infus bolu wherea rt-pa-delta fe/scu-pa- potent bolu bolu inject rt-pa rscu-pa synergist effect clot lysi synerg combin bolu inject combin infus rt-pa rt-pa-delta fe/scu-pa- rscu-pa rt-pa-delta fe/scu-pa- present studi rt-pa-delta fe/scu-pa- potent clot lysi rt-pa rscu-pa bolu inject synergist interact chimera rt-pa rscu-pa